Transparency or Independence in Conflict of Interest Disclosures

Affiliations

Alain Braillon. JAMA Oncol. 2016.

. 2016 Dec 1;2(12):1661.

doi: 10.1001/jamaoncol.2016.4908.

No abstract available

Similar articles

The murky world of disclosures.
Sidaway P. Sidaway P. Nat Rev Clin Oncol. 2018 Nov;15(11):651. doi: 10.1038/s41571-018-0106-z. Nat Rev Clin Oncol. 2018. PMID: 30262918 No abstract available.
American Society of Clinical Oncology policy for relationships with companies: background and rationale.
American Society of Clinical Oncology. American Society of Clinical Oncology. J Clin Oncol. 2013 Jun 1;31(16):2037-42. doi: 10.1200/JCO.2013.49.4997. Epub 2013 Apr 22. J Clin Oncol. 2013. PMID: 23610121
American Society of Clinical Oncology: Policy for relationships with companies.
American Society of Clinical Oncology. American Society of Clinical Oncology. J Clin Oncol. 2013 Jun 1;31(16):2043-6. doi: 10.1200/JCO.2013.49.5002. Epub 2013 Apr 22. J Clin Oncol. 2013. PMID: 23610118 No abstract available.
Improving the disclosure of conflicts of interest in medicine.
Arnold D. Arnold D. Clin Adv Hematol Oncol. 2019 Jul;17(7):393-394. Clin Adv Hematol Oncol. 2019. PMID: 31449505 Review. No abstract available.
Family history and adoption in the UK: conflicts of interest in medical disclosure.
Hill CM, Wheeler R, Merredew F, Lucassen A. Hill CM, et al. Arch Dis Child. 2010 Jan;95(1):7-11. doi: 10.1136/adc.2009.164970. Arch Dis Child. 2010. PMID: 20040680 Review. No abstract available.